KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Zoe Lofgren (House) disclosed 10 transactions

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

Amendment status is not available for House filings. A filing listed here may since have been amended.

2018-08-30 · sellu.S. bancorp (uSb) — $1,001 - $15,000
2018-08-07 · sellStarbucks Corporation (SbuX) — $1,001 - $15,000
2018-08-30 · sellPPL Corporation — $1,001 - $15,000
2018-08-30 · sellLennox International, Inc. — $1,001 - $15,000
2018-08-30 · sellgramercy Property Trust (gPT) — $1,001 - $15,000
2018-08-30 · sellglaxoSmithKline PLC (gSK) — $1,001 - $15,000
2018-08-30 · sellgeneral Mills, Inc. (gIS) — $1,001 - $15,000
2018-08-30 · sellEli Lilly and Company — $1,001 - $15,000
2018-08-30 · sellVulcan Materials Company — $1,001 - $15,000
2018-08-30 · sellCelgene Corporation (CELg) — $1,001 - $15,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerSpouse
partyDemocrat
stateCA
officeLofgren, Zoe (Representative)
ptr id20010292
chamberhouse
comment—
amount max15000
amount min1001
asset typeST
report urlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2018/20010292.pdf
bioguide idL000397
data sourceHOUSE_CLERK_PTR
member lastLofgren
member nameZoe Lofgren
amount range$1,001 - $15,000
member firstZoe
state districtCA19
disclosure date2018-09-13
transaction typesell
transaction natureOPEN_MARKET

Each transaction (10)

idtickerasset nametransaction datereporting lag days
house-20010292-9USBu.S. bancorp (uSb)2018-08-3010
house-20010292-8SBUXStarbucks Corporation (SbuX)2018-08-0727
house-20010292-7PPLPPL Corporation2018-08-3010
house-20010292-6LIILennox International, Inc.2018-08-3010
house-20010292-5GPTgramercy Property Trust (gPT)2018-08-3010
house-20010292-4GSKglaxoSmithKline PLC (gSK)2018-08-3010
house-20010292-3GISgeneral Mills, Inc. (gIS)2018-08-3010
house-20010292-2LLYEli Lilly and Company2018-08-3010
house-20010292-10VMCVulcan Materials Company2018-08-3010
house-20010292-1CELGCelgene Corporation (CELg)2018-08-3010

Original filing document